0000919574-23-004721.txt : 20230814
0000919574-23-004721.hdr.sgml : 20230814
20230814113539
ACCESSION NUMBER: 0000919574-23-004721
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
EFFECTIVENESS DATE: 20230814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAXTON CORP
CENTRAL INDEX KEY: 0001388551
IRS NUMBER: 222437619
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15293
FILM NUMBER: 231167559
BUSINESS ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2, SUITE 500
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-419-1800
MAIL ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2, SUITE 500
CITY: PRINCETON
STATE: NJ
ZIP: 08540
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
true
false
0001388551
XXXXXXXX
06-30-2023
06-30-2023
false
CAXTON CORP
731 Alexander Road
Building 2, Suite 500
Princeton
NJ
08540
13F HOLDINGS REPORT
028-15293
N
Heath Weisberg
Chief Compliance Officer
212-205-6805
/s/ Heath Weisberg
Princeton
NJ
08-14-2023
0
7
34653386
true
INFORMATION TABLE
2
infotable.xml
ALLAKOS INC
COM
01671P100
77318
17733
SH
SOLE
17733
0
0
COMPASS THERAPEUTICS INC
COM
20454B104
138220
43466
SH
SOLE
43466
0
0
ELEVATION ONCOLOGY INC
COM
28623U101
33022
21725
SH
SOLE
21725
0
0
MOLECULAR TEMPLATES INC
COM
608550109
985436
2052991
SH
SOLE
2052991
0
0
REZOLUTE INC
COM NEW
76200L309
2611555
1318967
SH
SOLE
1318967
0
0
SAVARA INC
COM
805111101
16026005
4980804
SH
SOLE
4980804
0
0
XERIS BIOPHARMA HOLDINGS INC
COM
98422E103
14781830
5641920
SH
SOLE
5641920
0
0